Comparative efficacy of 19 drug therapies for patients with idiopathic thrombocytopenic purpura: a multiple-treatments network meta-analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00277-022-04784-0.pdf
Reference35 articles.
1. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):2386–2393. https://doi.org/10.1182/blood-2008-07-162503
2. Schulze H, Gaedicke G (2011) Immune thrombocytopenia in children and adults: what’s the same, what’s different? Haematologica 96(12):1739–1741. https://doi.org/10.3324/haematol.2011.055830
3. Cuker A, Cines DB, Neunert CE (2016) Controversies in the treatment of immune thrombocytopenia. Curr Opin Hematol 23(5):479–485. https://doi.org/10.1097/MOH.0000000000000270
4. Zaja F, Baccarani M, Mazza P, Bocchia M, Gugliotta L, Zaccaria A, Vianelli N, Defina M, Tieghi A, Amadori S, Campagna S, Ferrara F, Angelucci E, Usala E, Cantoni S, Visani G, Fornaro A, Rizzi R, De Stefano V, Casulli F, Battista ML, Isola M, Soldano F, Gamba E, Fanin R (2010) Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood 115(14):2755–2762. https://doi.org/10.1182/blood-2009-07-229815
5. Gudbrandsdottir S, Birgens HS, Frederiksen H, Jensen BA, Jensen MK, Kjeldsen L, Klausen TW, Larsen H, Mourits-Andersen HT, Nielsen CH, Nielsen OJ, Plesner T, Pulczynski S, Rasmussen IH, Ronnov-Jessen D, Hasselbalch HC (2013) Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia. Blood 121(11):1976–1981. https://doi.org/10.1182/blood-2012-09-455691
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Primary immune thrombocytopenic purpura with exuberant oral manifestations in a patient with Turner syndrome;Special Care in Dentistry;2024-07-11
2. The 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopenia;Blood Advances;2024-07-09
3. Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics;Hämostaseologie;2024-06-26
4. Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials;Annals of Hematology;2024-06-10
5. Efficacy and Safety of Fostamatinib in Refractory Immune Thrombocytopenia: A Meta-analysis from Randomized Controlled Trials;SSRN Electronic Journal;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3